Work

Bevacizumab Beyond Progression: Impact of Subsequent Bevacizumab Re-Treatment in Patients with Ovarian, Fallopian Tube, and Peritoneal Cancer after Progression

Year: 2024

Type: article

Study design: Observational Study

Source: Gynecologic Oncology

Authors: Amma Asare, Rebecca Ann Previs, Daniel Spinosa, Bryan Fellman, Amelia L. Scott, Isabelle Mulder, May Mahmoud, Ahmed Enbaya, Jean Hansen Siedel, Lauren Cobb, Pamela T. Soliman, Anil K. Sood, Robert L. Coleman, Angeles Alvarez Secord, Shannon N. Westin

Institutions: The University of Texas MD Anderson Cancer Center, LabCorp (United States), University of Colorado Cancer Center, Duke Medical Center, Texas Oncology

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: American Cancer Society, Foundation for Women's Cancer, Ovarian Cancer Research Alliance, National Institutes of Health, National Cancer Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: G111615301, G1901027039, G2246080663, G3893244596, G6303305467, G9000312660, Duke Women's Reproductive Health Research Scholars

OpenAlex ID: W4407856756

FWCI: 0.649

Cites: 26

Cited by: 2

Related to: 10